XAIR stock forecast
Our latest prediction for Beyond Air, Inc.'s stock price was made on the Dec. 30, 2019 when the stock price was at 4.60$.
In the short term (2weeks), XAIR's stock price should underperform the market by -2.83%. During that period the price should oscillate between -10.41% and +14.45%.
In the medium term (3months), XAIR's stock price should underperform the market by -9.50%. During that period the price should oscillate between -38.72% and +33.66%.Get email alerts
About Beyond Air, Inc.
Beyond Air, Inc. is a clinical-stage medical device and biopharmaceutical company. It engages in the developing a nitric oxide generator and delivery system that uses nitric oxide generated from ambient air and delivers precise amounts of nitric oxide to the lungs for the potential treatment of respiratory and other diseases. The company develops LungFit platform system, a generator and delivery system that produces nitric oxide from ambient air, eliminating the need for expensive and cumbersome cylinders. Beyond Air was founded in 2011 and is headquartered in Garden City, NY.
At the moment the company generates 9M USD in revenues.
On its last earning announcement, the company reported a loss of -0.91$ per share.
The book value per share is 0.51$
Three months stock forecastDec. 30, 2019
|Revenue USD||Gross Margin||Operating Income||Operating Margin||Net Income||Earnings Per Share||Dividends||Payout Ratio||Shares||Book Value Per Share||Operating Cash Flow||Cap Spending||Free Cash Flow|